During the last session, ClearPoint Neuro Inc (NASDAQ:CLPT)’s traded shares were 0.3 million, with the beta value of the company hitting 0.99. At the end of the trading day, the stock’s price was $8.88, reflecting an intraday loss of -1.99% or -$0.18. The 52-week high for the CLPT share is $9.06, that puts it down -2.03 from that peak though still a striking 54.39% gain since the share price plummeted to a 52-week low of $4.05. The company’s market capitalization is $245.09M, and the average intraday trading volume over the past 10 days was 0.21 million shares, and the average trade volume was 221.61K shares over the past three months.
ClearPoint Neuro Inc (NASDAQ:CLPT) trade information
ClearPoint Neuro Inc (CLPT) registered a -1.99% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -1.99% in intraday trading to $8.88, hitting a weekly high. The stock’s 5-day price performance is 27.59%, and it has moved by 15.93% in 30 days. Based on these gigs, the overall price performance for the year is 42.77%. The short interest in ClearPoint Neuro Inc (NASDAQ:CLPT) is 0.86 million shares and it means that shorts have 2.25 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The consensus price target of analysts on Wall Street is $9, which implies an increase of 1.33% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $9 and $9 respectively. As a result, CLPT is trading at a discount of -1.35% off the target high and -1.35% off the low.
ClearPoint Neuro Inc (CLPT) estimates and forecasts
Statistics show that ClearPoint Neuro Inc has outperformed its competitors in share price, compared to the industry in which it operates. ClearPoint Neuro Inc (CLPT) shares have gone up 25.42% during the last six months, with a year-to-date growth rate more than the industry average at 26.67% against 11.20. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 15.00% this quarter and then jump 10.50% in the quarter after that. In the rating firms’ projections, revenue will increase 27.40% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 7.56M as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 7.95M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 5.76M and 6.81M respectively. In this case, analysts expect current quarter sales to grow by 31.20% and then jump by 16.70% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -9.74%. While earnings are projected to return 25.37% in 2024, the next five years will return 30.00% per annum.
CLPT Dividends
ClearPoint Neuro Inc is due to release its next quarterly earnings 2024-Nov-07. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
ClearPoint Neuro Inc (NASDAQ:CLPT)’s Major holders
ClearPoint Neuro Inc insiders own 7.92% of total outstanding shares while institutional holders control 32.26%, with the float percentage being 35.03%. BLACKROCK INC. is the largest shareholder of the company, while 110.0 institutions own stock in it. As of 2024-03-31, the company held over 1.47 million shares (or 5.9905% of all shares), a total value of $10.02 million in shares.
The next largest institutional holding, with 1.31 million shares, is of VANGUARD GROUP INC’s that is approximately 5.3147% of outstanding shares. At the market price on 2024-03-31, these shares were valued at $8.89 million.
Also, the Mutual Funds coming in first place with the largest holdings of ClearPoint Neuro Inc (CLPT) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Mar 31, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 780.41 shares. This amounts to just over 2.85 percent of the company’s overall shares, with a $6.93 million market value. The same data shows that the other fund manager holds slightly less at 344.39, or about 1.26% of the stock, which is worth about $3.06 million.
